Citadel Advisors »

Telix Pharmaceutical Ltd Sponsored shares owned by Citadel Advisors

Quarter-by-quarter ownership of Telix Pharmaceutical Ltd Sponsored (TLX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Telix Pharmaceutical Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Telix Pharmaceutical Ltd Sponsored held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telix Pharmaceutical Ltd Sponsored by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $172k 23k 7.49
2025-06-30 $668k 41k 16.17

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Telix Pharmaceutical Ltd Sponsored

Portland Investment Counsel
Lazard Asset Management
Private Advisor
Raiffeisen Bank International
FMR
Marshall Wace
Jane Street
Quadrature Capital
Mariner Wealth Advisors
Vident Advisory
IHT Wealth Management
Citadel Advisors
Millennium Management
Point72 Asset Management
JustInvest

View all funds holding Telix Pharmaceutical Ltd Sponsored